1-2 of 2
Michele Rosner, MS
Close
Sort by
Journal Articles

Phase 1 Results of FF-10501-01, a Novel Inosine 5'-Monophosphate Dehydrogenase Inhibitor, in Advanced Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes (MDS), Including Hypomethylating Agent (HMA) Failures

Guillermo Garcia-Manero, MD, Hui Yang, MD PhD, Zhihong Fang, Hagop M. Kantarjian, MD, Courtney D. DiNardo, MD MSCE, Elias J. Jabbour, MD, Naveen Pemmaraju, MD, Naval Daver, MD, Ricardo Delumpa, RN, Christopher Loiselle, RN, Silvia Rivera, MS, Kristin Anderson, BS, Brittany Yearby, BS, Susan Denton, RN, Whitney Smith, BS, Kathleen Tiefenwerth, RN, Hiroyuki Iwamura, Dphil, Teletha Gipson, PhD, Michele Rosner, MS, Thomas J. Myers, MD, Linda J. Paradiso, DVM, MBA
Journal: Blood
Blood (2016) 128 (22): 1640.
https://doi.org/10.1182/blood.V128.22.1640.1640
Published: 2016
Journal Articles

Anti-Leukemia Effect of FF-10501-01, a Novel Inosine 5'-Monophosphate Dehydrogenase Inhibitor, in Advanced Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes (MDS), Including Hypomethylating Agent (HMA) Failures

Guillermo Garcia-Manero, MD, Hui Yang, MD PhD, Zhihong Fang, Courtney DiNardo, MD, Elias Jabbour, MD, Naveen Pemmaraju, MD, Ricardo Delumpa, RN, Christopher Loiselle, RN, Susan Denton, RN, Whitney Smith, Hiroyuki Iwamura, PhD, Teletha Gipson, PhD, Michele Rosner, MS, Timothy Madden, PharmD, Thomas J. Myers, MD, Linda J. Paradiso, DVM, MBA
Journal: Blood
Blood (2015) 126 (23): 3800.
https://doi.org/10.1182/blood.V126.23.3800.3800
Published: 2015